Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma
- PMID: 6409012
- DOI: 10.1007/BF00412878
Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma
Abstract
Cysteinyldopas and Dopa in the urine and tissues of Japanese melanoma patients were investigated quantitatively by means of high-performance liquid chromatography. Cysteinyldopa isomers were detected in the urine of eumelanic Japanese patients. The amount (X +/- SD%) of each isomer of cysteinyldopa in the urine was 80.26 +/- 4.66% in 5-S-cysteinyldopa, 9.39 +/- 1.64% in 2-S-cysteinyldopa, 7.07 +/- 3.33% in 2, 5-S, S-dicysteinyldopa, and 3.28 +/- 1.43% in 6-S-cysteinyldopa. The amount of cysteinyldopa in melanoma tissues was 26-314 times more than that of Dopa. The amount (X +/- SD%) of cysteinyldopa in the tissues was 80.34 +/- 1.75% in 5-S-cysteinyldopa, 11.06 +/- 1.91% in 2-S-cysteinyldopa, 6.27 +/- 1.43% in 2, 5-S, S-dicysteinyldopa, and 2.34 +/- 0.61% in 6-S-cysteinyldopa. The fact that the percentages of each isomer of cysteinyldopa in the urine and in the tissues were approximately constant suggests that the cysteinyldopas secreted from melanoma cells were excreted into the urine without being metabolized.
Similar articles
-
[Contents of cysteinyldopa isomers and DOPA in lesions of malignant melanoma (author's transl)].Nihon Hifuka Gakkai Zasshi. 1982 Feb;92(2):157-9. Nihon Hifuka Gakkai Zasshi. 1982. PMID: 6806514 Japanese. No abstract available.
-
5-S-cysteinyldopa in the urine of melanoma patients.Acta Derm Venereol. 1977;57(2):113-6. Acta Derm Venereol. 1977. PMID: 71802
-
[5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].Z Hautkr. 1983 Feb 15;58(4):262-5. Z Hautkr. 1983. PMID: 6405551 German.
-
Detection and quantitation of 5-S-cysteinyldopa in melanotic and amelanotic melanoma in comparison with nonpigment cell tumors and it's urinary excretion.J Dermatol. 1979 Dec;6(6):379-82. doi: 10.1111/j.1346-8138.1979.tb01931.x. J Dermatol. 1979. PMID: 120380 No abstract available.
-
Significance of 5-S-Cysteinyldopa as a Marker for Melanoma.Int J Mol Sci. 2020 Jan 9;21(2):432. doi: 10.3390/ijms21020432. Int J Mol Sci. 2020. PMID: 31936623 Free PMC article. Review.
Cited by
-
Tyrosinase-catalyzed conjugation of dopa with glutathione.Experientia. 1985 Jul 15;41(7):960-1. doi: 10.1007/BF01970033. Experientia. 1985. PMID: 3924652
-
Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues.Arch Dermatol Res. 1983;275(5):329-33. doi: 10.1007/BF00417207. Arch Dermatol Res. 1983. PMID: 6419680
-
Quantitative analysis of eumelanin and pheomelanin in human malignant-melanoma tissues.Arch Dermatol Res. 1985;277(3):248-50. doi: 10.1007/BF00404326. Arch Dermatol Res. 1985. PMID: 4015188 No abstract available.
-
Preoperative diagnosis of malignant melanoma using the touch-fluorescence method.Surg Today. 1993;23(7):580-6. doi: 10.1007/BF00311904. Surg Today. 1993. PMID: 8369608
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical